48 related articles for article (PubMed ID: 38503527)
1. CD34+ CD90+ cells and late hematopoietic reconstitution after autologous peripheral blood stem cell transplantation.
Shimazaki C; Sumikuma T; Inaba T
Leuk Lymphoma; 2004 Apr; 45(4):661-8. PubMed ID: 15160937
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 8 cases of refractory hematopoietic reconstitution after haploid hematopoietic stem cell transplantation treated with purified donor CD34-selected hematopoietic stem cells].
He Y; Ma R; Wang HF; Zhang YY; Lyu M; Mo XD; Yan CH; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1027-1031. PubMed ID: 38503527
[No Abstract] [Full Text] [Related]
3. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
Michallet M; Philip T; Philip I; Godinot H; Sebban C; Salles G; Thiebaut A; Biron P; Lopez F; Mazars P; Roubi N; Leemhuis T; Hanania E; Reading C; Fine G; Atkinson K; Juttner C; Coiffier B; Fière D; Archimbaud E
Exp Hematol; 2000 Jul; 28(7):858-70. PubMed ID: 10907648
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA sequence heterogeneity of single CD34+ cells after nonmyeloablative allogeneic stem cell transplantation.
Yao YG; Childs RW; Kajigaya S; McCoy JP; Young NS
Stem Cells; 2007 Oct; 25(10):2670-6. PubMed ID: 17628021
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood harvest of unaffected CD34+ CD38- hematopoietic precursors in paroxysmal nocturnal hemoglobinuria.
Prince GM; Nguyen M; Lazarus HM; Brodsky RA; Terstappen LW; Medof ME
Blood; 1995 Nov; 86(9):3381-6. PubMed ID: 7579441
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
Burt RK
Stem Cells; 1999; 17(6):373-6. PubMed ID: 10606166
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.
Prabahran A; Koldej R; Chee L; Ritchie D
Blood Adv; 2022 Mar; 6(6):1947-1959. PubMed ID: 34492685
[TBL] [Abstract][Full Text] [Related]
9. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
10. Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Cuadrado MM; Szydlo RM; Watts M; Patel N; Renshaw H; Dorman J; Lowdell M; Ings S; Anthias C; Madrigal A; Mackinnon S; Kottaridis P; Carpenter B; Hough R; Morris E; Thomson K; Peggs KS; Chakraverty R
Haematologica; 2020 Nov; 105(11):2639-2646. PubMed ID: 33131253
[TBL] [Abstract][Full Text] [Related]
11. Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation.
Chen J; Wang H; Zhou J; Feng S
Ther Adv Hematol; 2020; 11():2040620720948743. PubMed ID: 32874483
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Risk Factors, and Outcomes of Primary Prolonged Isolated Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplant.
Tang FF; Sun YQ; Mo XD; Lv M; Chen YH; Wang Y; Xu LP; Zhang XH; Huang XJ
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1452-1458. PubMed ID: 32311479
[TBL] [Abstract][Full Text] [Related]
13. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights
Kong Y
Semin Hematol; 2019 Jul; 56(3):215-220. PubMed ID: 31202433
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
Zhao Y; Gao F; Shi J; Luo Y; Tan Y; Lai X; Yu J; Huang H
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1898-1907. PubMed ID: 31176790
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
